New Diagnostic Test Follows Footsteps Leading to Esophageal Cancer

Share this content:

the Cancer Therapy Advisor take:

Frequent acid reflux, if left untreated, damages esaphageal cells and may lead to Barrett’s esophagus, a potential precursor of esophageal cancer. However, most patients with Barrett’s esophagus will not progress to esophageal cancer.

According to a study published in Nature Genetics, the discovery of a gene mutation that marks the pathway from a relatively harmless esophageal condition to cancer can lead to the development of a diagnostic test for patients with Barrett’s esophagus.

Study author Rebecca Fitzgerald and researchers mapped out the genetic similarities and differences between patients with Barrett’s esophagus and patients with esophageal cancer. Through this process, researchers discovered mutations in the gene TP53.

They developed a sponge-on-a-string test, also called the Cytosponge test, in which a patient swallows a capsule attached to a piece of thread. Once the capsule reaches the stomach, it dissolves to reveal a sponge underneath. Then a nurse uses the string to pull the sponge out to collect cells from the esophagus.

Fitzgerald said she hopes the Cytosponge test will be routinely available in hospitals in the near future. This will allow patients to be diagnosed at early stages of the disease, where treatment has a greater chance of being effective. Currently, even Barrett’s esophagus is widely undiagnosed.

Induction Chemotherapy to Downstage Advanced Oesophageal Cancer Before Surgery
New Diagnostic Test Follows Footsteps Leading to Esophageal Cancer

A new diagnostic test may be around the corner thanks to the discovery of a gene mutation that marks the progression from a harmless esophageal condition to cancer, according to research published in Nature Genetics. Over time, frequent acid reflux—often called heartburn—damages the cells in the esophagus.

Scientists funded by Cancer Research UK's Catalyst Club, and working as part of the International Cancer Genome Consortium (ICGC), have identified the faults that signal the early onset of esophageal cancer.

READ FULL ARTICLE From Medical Express

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs